179 related articles for article (PubMed ID: 30108282)
1. Linear isoforms of the long noncoding RNA CDKN2B-AS1 regulate the c-myc-enhancer binding factor RBMS1.
Hubberten M; Bochenek G; Chen H; Häsler R; Wiehe R; Rosenstiel P; Jepsen S; Dommisch H; Schaefer AS
Eur J Hum Genet; 2019 Jan; 27(1):80-89. PubMed ID: 30108282
[TBL] [Abstract][Full Text] [Related]
2. Linear and circular CDKN2B-AS1 expression is associated with Inflammatory Bowel Disease and participates in intestinal barrier formation.
Rankin CR; Lokhandwala ZA; Huang R; Pekow J; Pothoulakis C; Padua D
Life Sci; 2019 Aug; 231():116571. PubMed ID: 31207308
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA CDKN2B-AS1 interacts with transcription factor BCL11A to regulate progression of cerebral infarction through mediating MAP4K1 transcription.
Lei JJ; Li HQ; Mo ZH; Liu KJ; Zhu LJ; Li CY; Chen WL; Zhang L
FASEB J; 2019 Jun; 33(6):7037-7048. PubMed ID: 30870006
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA CDKN2B-AS1 contributes to atherosclerotic plaque formation by forming RNA-DNA triplex in the CDKN2B promoter.
Ou M; Li X; Zhao S; Cui S; Tu J
EBioMedicine; 2020 May; 55():102694. PubMed ID: 32335370
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CDKN2B-AS1 reduces inflammatory response and promotes cholesterol efflux in atherosclerosis by inhibiting ADAM10 expression.
Li H; Han S; Sun Q; Yao Y; Li S; Yuan C; Zhang B; Jing B; Wu J; Song Y; Wang H
Aging (Albany NY); 2019 Mar; 11(6):1695-1715. PubMed ID: 30926762
[TBL] [Abstract][Full Text] [Related]
6. Overexpressed lncRNA CDKN2B-AS1 is an independent prognostic factor for liver cancer and promotes its proliferation.
Zhuang H; Cao G; Kou C; Li D
J BUON; 2019; 24(4):1441-1448. PubMed ID: 31646789
[TBL] [Abstract][Full Text] [Related]
7. CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases.
Song C; Qi Y; Zhang J; Guo C; Yuan C
Curr Pharm Des; 2020; 26(41):5335-5346. PubMed ID: 32767927
[TBL] [Abstract][Full Text] [Related]
8. LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis.
Xu C; Zhai J; Fu Y
Neoplasma; 2020 Jul; 67(4):782-793. PubMed ID: 32305052
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CDKN2B-AS1 interacts with miR-411-3p to regulate ovarian cancer in vitro and in vivo through HIF-1a/VEGF/P38 pathway.
Wang Y; Huang Y; Liu H; Su D; Luo F; Zhou F
Biochem Biophys Res Commun; 2019 Jun; 514(1):44-50. PubMed ID: 31014670
[TBL] [Abstract][Full Text] [Related]
10. Analysis of ANRIL Isoforms and Key Genes in Patients with Severe Coronary Artery Disease.
Rodríguez-Esparragón F; Torres-Mata LB; Cazorla-Rivero SE; Serna Gómez JA; González Martín JM; Cánovas-Molina Á; Medina-Suárez JA; González-Hernández AN; Estupiñán-Quintana L; Bartolomé-Durán MC; Rodríguez-Pérez JC; Varas BC
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003316
[TBL] [Abstract][Full Text] [Related]
11.
Luo Y; Tao H; Jin L; Xiang W; Guo W
Cancer Biother Radiopharm; 2020 Feb; 35(1):58-65. PubMed ID: 31724892
[No Abstract] [Full Text] [Related]
12. A natural antisense lncRNA controls breast cancer progression by promoting tumor suppressor gene mRNA stability.
Jadaliha M; Gholamalamdari O; Tang W; Zhang Y; Petracovici A; Hao Q; Tariq A; Kim TG; Holton SE; Singh DK; Li XL; Freier SM; Ambs S; Bhargava R; Lal A; Prasanth SG; Ma J; Prasanth KV
PLoS Genet; 2018 Nov; 14(11):e1007802. PubMed ID: 30496290
[TBL] [Abstract][Full Text] [Related]
13. New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (
Yuan W; Zhang W; Zhang W; Ruan ZB; Zhu L; Liu Y; Mi YY; Zhang LF
Bioengineered; 2020 Dec; 11(1):1084-1098. PubMed ID: 33054494
[TBL] [Abstract][Full Text] [Related]
14. Low expression of long noncoding RNA CDKN2B-AS1 in patients with idiopathic pulmonary fibrosis predicts lung cancer by regulating the p53-signaling pathway.
Du Y; Hao X; Liu X
Oncol Lett; 2018 Apr; 15(4):4912-4918. PubMed ID: 29541247
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA CDKN2B-AS1 promotes osteosarcoma by increasing the expression of MAP3K3 via sponging miR-4458.
Gui D; Cao H
In Vitro Cell Dev Biol Anim; 2020 Jan; 56(1):24-33. PubMed ID: 31950433
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA FGF13-AS1 inhibits glycolysis and stemness properties of breast cancer cells through FGF13-AS1/IGF2BPs/Myc feedback loop.
Ma F; Liu X; Zhou S; Li W; Liu C; Chadwick M; Qian C
Cancer Lett; 2019 May; 450():63-75. PubMed ID: 30771425
[TBL] [Abstract][Full Text] [Related]
17. Host Gene Expression Is Regulated by Two Types of Noncoding RNAs Transcribed from the Epstein-Barr Virus BamHI A Rightward Transcript Region.
Marquitz AR; Mathur A; Edwards RH; Raab-Traub N
J Virol; 2015 Nov; 89(22):11256-68. PubMed ID: 26311882
[TBL] [Abstract][Full Text] [Related]
18. Association of a Chromosome Locus 9p21.3 CDKN2B-AS1 Variant rs4977574 with Hypertension: The TAMRISK Study.
Kunnas T; Piesanen J; Nikkari ST
Genet Test Mol Biomarkers; 2018 May; 22(5):327-330. PubMed ID: 29791233
[TBL] [Abstract][Full Text] [Related]
19. The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10.
Bochenek G; Häsler R; El Mokhtari NE; König IR; Loos BG; Jepsen S; Rosenstiel P; Schreiber S; Schaefer AS
Hum Mol Genet; 2013 Nov; 22(22):4516-27. PubMed ID: 23813974
[TBL] [Abstract][Full Text] [Related]
20. Effects of CDKN2B-AS1 polymorphisms on the susceptibility to coronary heart disease.
Huang K; Zhong J; Li Q; Zhang W; Chen Z; Zhou Y; Wu M; Zhong Z; Lu S; Zhang S
Mol Genet Genomic Med; 2019 Nov; 7(11):e955. PubMed ID: 31496134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
